PUR003 is an inhaled substance that is proposed to assist in the treatment of asthma.
Study objectives are to :
1. to evaluate the safety of PUR003 in subjects with asthma, and
2. to evaluate the efficacy of PUR003 in assisting the treatment of asthma.
Phase:
Phase 1
Details
Lead Sponsor:
Pulmatrix Inc.
Collaborators:
McMaster University St. Joseph's Healthcare Hamilton / Firestone Institute for Respiratory Health